JEOL USA Announces Expansion of Board of Directors and Leadership Appointments
July 16, 2026
Peabody, Mass. — JEOL USA, Inc. has expanded its Board of Directors with the appointment of two members of its leadership team, Donna Gosselin and Steve Tryon. In addition, Dr. Thomas Isabell was appointed President of JEOL USA. Together, they bring decades of leadership experience spanning product management, applications, and field service, further strengthening the company's [...]
July 15, 2026
BREMEN, Germany -- Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of the DISQVER® clinical metagenomics platform from Noscendo GmbH. The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehensive WGS analysis directly from cell-free human blood samples DISQVER® enables metagenomic next-generation sequencing (mNGS) analysis of microbes directly from blood samples, further expanding Bruker's NGS-based [...]
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
July 15, 2026
FREMONT, Calif. -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the relocation of its previous Seattle-area operations to a dedicated facility designed to support research and development (R&D) while strengthening collaboration and customer engagement. The new site has been renovated [...]
Primrose Bio Awarded NIH Grant to Develop Genetic Medicine Drug Design Technology
July 15, 2026
$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy SAN DIEGO -- Primrose Bio, Inc., a company with proprietary biologic manufacturing technologies, today announced a $2 million, 24-month Direct-to-Phase II Small Business Innovation Research award from the National Center for Advancing Translational Sciences (NCATS), part of the [...]
NexMR Joins the Magritek Group to Push Benchtop NMR One Step Further
July 14, 2026
The operation brings photohyperpolarization technology to the Spinsolve platform and benchtop NMR biophysics. "This is what real innovation in benchtop NMR looks like, and it is happening here.” — Federico Casanova AACHEN, NORTH RHINE-WESTPHALIA, GERMANY -- Magritek, the global leader in benchtop nuclear magnetic resonance (NMR) instrumentation, today announced that NexMR, developer of advanced photohyperpolarization technology, [...]
July 14, 2026
San Francisco, California - Yavne, Israel – Genopore, the next-generation proteomics company developing the first semiconductor based optical nanopore technology platform with AI/ML analysis for direct single protein molecule identification and digital quantification, today announced the appointment of life science leader Rey Mali as its new Chief Executive Officer, with immediate effect. Rey Mali brings more [...]
July 14, 2026
this appointment reflects the company's continued growth through investment in leadership that pairs deep scientific credibility with real-world R&D experience SAN DIEGO -- Rancho BioSciences today announced the appointment of John Reynders, PhD, MBA, to its Board of Directors. In his board role, Dr. Reynders will bring strategic depth to Rancho's product direction and growth [...]
July 14, 2026
GCMS-TQ8040 RX (Left) and GCMS-TQ8050 RX (Right) Gas Chromatograph-Mass Spectrometers On July 8, Shimadzu Corporation announced the release of the GCMS-TQ8040 RX and GCMS-TQ8050 RX gas chromatograph-mass spectrometers. The two models in the GCMS-TQ RX Series are triple quadrupole (TQ) gas chromatograph-mass spectrometers that combine industry-leading analytical performance with flexibility to meet diverse laboratory needs. The [...]
Element Biosciences Prevails in German Patent Case Against Illumina
July 14, 2026
Munich Regional Court finds Illumina infringes Element sequencing intellectual property, enjoins supply of Illumina systems and related consumables, and orders recall of affected devices SAN DIEGO, CA — Element Biosciences, Inc. today announced that the Regional Court of Munich I (Landgericht München I) has ruled that Illumina, Inc. and its German subsidiary, Illumina GmbH, infringe [...]
Nabsys Announces New 30,000-Square-Foot Headquarters in Providence, Rhode Island
July 14, 2026
ꟷ New, purpose-built facility at 225 Dyer Street in the 195 District reinforces Nabsys' commitment to Providence's growing life sciences and innovation district ꟷ Company will relocate its headquarters in July 2027, bringing manufacturing, technology development, R&D, and G&A together under one roof ꟷ Expansion supported by Rhode Island's life sciences ecosystem and state economic development initiatives PROVIDENCE, [...]

